Broad-spectrum forensic toxicological screening for 400+ substances by LC-MS/MS from whole blood or urine.
This comprehensive screening method detects over 400 psychoactive substances, providing the broadest available forensic toxicological coverage for unknown substance identification.
Clinical indications include:
400+ substances including classical drugs of abuse, designer drugs and novel psychoactive substances (NPS), psychotropic medications, barbiturates, synthetic cannabinoids, synthetic cathinones, and novel synthetic opioids.
Broad-spectrum screening by high-resolution LC-MS/MS with library matching against a continuously updated database of 400+ substances. Includes novel psychoactive substances and designer drugs not covered by conventional targeted panels.
Forensic Screen is an important biomarker for unknown substance identification in forensic cases. Masdiag measures forensic screen using validated analytical methods to provide clinically actionable results.
Forensic Screen testing is valuable for Unknown substance identification in forensic cases, Comprehensive post-mortem toxicological analysis. Understanding forensic screen levels helps inform personalized health optimization and clinical decision-making.
Forensic Screen is measured from blood. Professional collection ensures proper sample handling and accurate results.
This test is recommended for individuals interested in unknown substance identification in forensic cases. Masdiag forensic screen testing helps guide personalized supplementation and health optimization strategies based on objective biomarker data.
Forensic Screen results provide insight into your metabolic status and unknown substance identification in forensic cases. Combined with clinical context, Masdiag results inform evidence-based interventions for personalized health optimization.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.